Matthias Wirth

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Multiple Myeloma

Transcription Factor

Dna Damage Response

Top Venues

Cancer research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Matthias Wirth, Günter Schneider
A Hypoxia-Epigenetics Axis Drives EMT in Pancreatic Cancer. Cancer research 84 (11) (2024)
Matthias Wirth, Walburgis Brenner, Oliver Holger Krämer
Boosting T cell immunity against cytomegalovirus: a potential strategy combating human aging and age-related diseases. Signal transduction and targeted therapy 8 (1) (2023)
Le Zhang, Matthias Wirth, Upayan Patra, Jacob Stroh, Konstandina Isaakidis, Leonie Rieger, Susanne Kossatz, Maja Milanovic, Chuanbing Zang, Uta Demel, Jan Keiten-Schmitz, Kristina Wagner, Katja Steiger, Roland Rad, Florian Bassermann, Stefan Müller, Ulrich Bernd Keller, Markus Schick
Actionable loss of SLF2 drives B-cell lymphomagenesis and impairs the DNA damage response. EMBO molecular medicine (2023)
Judith Dönig, Hannah Mende, Jimena Davila Gallesio, Kristina Wagner, Paul W Hotz, Kathrin Schunck, Tanja Piller, Soraya Hölper, Sara Uhan, Manuel Kaulich, Matthias Wirth, Ulrich Bernd Keller, Georg Tascher, Katherine E Bohnsack, Stefan Müller
Characterization of nucleolar SUMO isopeptidases unveils a general p53-independent checkpoint of impaired ribosome biogenesis. Nature communications 14 (1) (2023)
Ramy Ashry, Al-Hassan M Mustafa, Kristin Hausmann, Michael Linnebacher, Susanne Strand, Wolfgang Sippl, Matthias Wirth, Oliver Holger Krämer
NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor. Cancers 15 (14) (2023)
Carmen Paulmann, Ria Spallek, Oleksandra Karpiuk, Michael Heider, Isabell Schäffer, Jana Zecha, Susan Klaeger, Michaela Walzik, Rupert Öllinger, Thomas Engleitner, Matthias Wirth, Ulrich Bernd Keller, Jan Krönke, Martina Rudelius, Susanne Kossatz, Roland Rad, Bernhard Kuster, Florian Bassermann
The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma. The EMBO journal 41 (20) (2022)
Lukas Krauß, Bettina C Urban, Sieglinde Hastreiter, Carolin Schneider, Patrick Wenzel, Zonera Hassan, Matthias Wirth, Katharina Lankes, Andrea Terrasi, Christine Klement, Filippo M Cernilogar, Rupert Öllinger, Niklas de Andrade Krätzig, Thomas Engleitner, Roland M Schmid, Katja Steiger, Roland Rad, Oliver Holger Krämer, Maximilian Reichert, Gunnar Schotta, Dieter Saur, Günter Schneider
HDAC2 Facilitates Pancreatic Cancer Metastasis. Cancer research 82 (4) (2022)
Markus Schick, Le Zhang, Sabine Maurer, Hans Carlo Maurer, Konstandina Isaakaidis, Lara Schneider, Upayan Patra, Kathrin Schunck, Elena Rohleder, Julia Hofstetter, Apoorva Baluapuri, Anna Katharina Scherger, Julia Slotta-Huspenina, Franziska Hettler, Julia Weber, Thomas Engleitner, Roman Maresch, Jolanta Slawska, Richard Ian Lewis, Rouzanna Istvanffy, Stefan Habringer, Katja Steiger, Armin Baiker, Robert A J Oostendorp, Christoph Cornelius Miething, Hans-Peter Lenhof, Florian Bassermann, Bjoern Chapuy, Matthias Wirth, Elmar Wolf, Roland Rad, Stefan Müller, Ulrich Bernd Keller
Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma. Nature communications 13 (1) (2022)
Josefina Doffo, Stefanos A Bamopoulos, Hazal Köse, Felix Orben, Chuanbing Zang, Miriam Pons, Alexander T den Dekker, Rutger W W Brouwer, Apoorva Baluapuri, Stefan Habringer, Maximillian Reichert, Anuradha Illendula, Oliver H Krämer, Markus Schick, Elmar Wolf, Wilfred F J Van IJcken, Irene Esposito, Ulrich Bernd Keller, Günter Schneider, Matthias Wirth
NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (9) (2022)
Christian Schneeweis, Zonera Hassan, Katja Ascherl, Matthias Wirth, Stella Koutsouli, Felix Orben, Lukas Krauß, Carolin Schneider, Rupert Öllinger, Oliver H Krämer, Roland Rad, Maximilian Reichert, Maria S Robles, Dieter Saur, Günter Schneider
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition. Cancer communications (London, England) 42 (4) (2022)
Richard Ian Lewis, H Carlo Maurer, Nikita Singh, Irene Gonzalez-Menendez, Matthias Wirth, Markus Schick, Le Zhang, Konstandina Isaakidis, Anna Katharina Scherger, Veronika Schulze, Junyan Lu, Thorsten Zenz, Katja Steiger, Roland Rad, Leticia Quintanilla-Martinez, Marion Espeli, Karl Balabanian, Ulrich Bernd Keller, Stefan Habringer
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness. Leukemia 35 (10) (2021)
Yingfen Hong, Nikita Singh, Stefanos Bamopoulos, Enio Gjerga, Laura K Schmalbrock, Karl Balabanian, Markus Schick, Ulrich Bernd Keller, Matthias Wirth
Authentication of Primary Murine Cell Lines by a Microfluidics-Based Lab-On-Chip System. Biomedicines 8 (12) (2020)
Katharina Lankes, Zonera Hassan, María Josefina Doffo, Christian Schneeweis, Svenja Lier, Rupert Öllinger, Roland Rad, Oliver H Krämer, Ulrich Keller, Dieter Saur, Maximilian Reichert, Günter Schneider, Matthias Wirth
Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC. Molecular oncology 14 (12) (2020)
Matthias Wirth, Markus Schick, Ulrich Bernd Keller, Jan Krönke
Ubiquitination and Ubiquitin-Like Modifications in Multiple Myeloma: Biology and Therapy. Cancers 12 (12) (2020)